Yttrium-90 : A pilot study of combined modality treatment for hepatic metastases of uveal melanoma with intrahepatic Yttrium-90 radioembolisation and intravenous cisplatin.

Male or<br/>FemaleGender Male or
Female

RecruitingStatus Recruiting

Multiple<Br/>Treatment TypesTypeMultiple
Treatment Types

OnePhase One

18+Age Over 18

Head and Neck<br/>CancersCancer LocationHead and Neck
Cancers

Multiple treatment types,Radiotherapy,Systemic therapy | Head and neckMelanoma (Ocular)

Trial Overview Read MoreRead more

This phase I trial is combining radiation therapy and chemotherapy for patients with Uveal Melanoma (a cancer of the eye) that has spread to the liver.
 

This trial is treating patients with Uveal Melanoma (of the eye).

This is a systemic therapy trial.

You may be able to join this trial if:

  • Your cancer has spread to other parts of the body.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have had certain treatments, surgical procedures or drugs.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

A pilot study of combined modality treatment for hepatic metastases of uveal melanoma with intrahepatic Yttrium-90 radioembolisation and intravenous cisplatin.

Other Non-Commercial Sponsor

Ludwig Institute for Cancer Research

Summary

This trial is exploring the synergy between radiation therapy (using intrahepatic Yttrium-90 radioembolisation) and chemotherapy (with intravenous cisplatin) in the treatment of adult patients who have been diagnosed with a Uveal Melanoma that has metastasized to the liver.

Recruiting Hospitals Read MoreRead more

Olivia Newton-John Cancer Wellness & Research Centre
Heidelberg
Ms Samantha Chakar
samantha.chakar@austin.org.au
03 9496 3088

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next